Cantor Fitzgerald, L. P. Pfizer Inc Transaction History

Cantor Fitzgerald, L. P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $253,634 - $293,449	-7,022 Reduced 1.33%	522,043 $19.1 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $5.12 Million - $6.67 Million	130,100 Added 32.61%	529,065 $21.6 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $215,805 - $281,710	5,169 Added 1.31%	398,965 $20.5 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $36.2 Million - $44.2 Million	-828,092 Reduced 67.77%	393,796 $17.2 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $56.9 Million - $67.4 Million	1,221,888 New	1,221,888 $64.1 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Cantor Fitzgerald, L. P., based on Form 13F filings with the SEC.

Stay updated on Cantor Fitzgerald, L. P. with notifications on news.